Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients-Reference-Cited by-同舟云学术

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients

Published:2015-10-21 Issue:10 Volume:10 Page:e0141164
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Poizot-Martin Isabelle,Naqvi Alissa,Obry-Roguet Véronique,Valantin Marc-Antoine,Cuzin Lise,Billaud Eric,Cheret Antoine,Rey David,Jacomet Christine,Duvivier Claudine,Pugliese Pascal,Pradat Pierre,Cotte Laurent,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. HIV/hepatitis C coinfection natural history and disease progression;MD Hernandez;Curr Opin HIV AIDS,2011

2. Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France;P Cacoub;Liver Int,2015

3. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis;CS Graham;Clin Infect Dis,2001

4. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis;HH Thein;AIDS,2008

5. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies;EA Operskalski;Curr HIV/AIDS Rep,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Host microRNAomics in HIV Infections: Therapeutic Potentials and Limitations;International Journal of Molecular Sciences;2024-08-13

2. Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices;Pharmaceuticals;2022-02-18

3. The treatment choices and outcome of hepatocellular carcinoma in hemophilic patients with human immunodeficiency virus/hepatitis C virus (HIV/HCV) coinfection due to contaminated blood products in Japan;Journal of Gastrointestinal Oncology;2021-12

4. Single‐pill sofosbuvir and daclatasvir for treating hepatis C in patients co‐infected with human immunodeficiency virus;International Journal of Clinical Practice;2021-05-17

5. Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19;European Journal of Clinical Pharmacology;2021-03-04